Cannabidiol Research: Osteoporosis

• CBD Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts
• Cannabinoid receptors as target for treatment of osteoporosis: A tale of two therapies
• Cannabinoids and bone: Friend or foe?
• Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells
• Cannabinoids and the skeleton: From marijuana to reversal of bone loss
• The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy
• The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption
• Endocannabinoids and the regulation of bone metabolism
• Cannabinoid receptors and the regulation of bone mass
• Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health
• Peripheral cannabinoid receptor, CB2, regulates bone mass
• Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
• Long-chain polyunsaturated fatty acids may mutually benefit both obesity and osteoporosis
• Skeletal lipidomics: Regulation of bone metabolism by fatty acid amide family